FDA Inspection
Haematologic Technologies, LLC dba ProlytixHaematologic Technologies, LLC dba Prolytix – FDA Inspection, Apr 17, 2026
Record Details
This FDA Inspection record concerns Haematologic Technologies, LLC dba Prolytix, with an inspection on April 17, 2026, issued by the New England District Office, covering biologics.
- Inspection Date
- April 17, 2026
- Product Type
- Biologics
View Company Profile
ID · 0542f691-8e6c-4a69-b14f-629cd185c8ad
Inspection Facts
- Inspection number
- 1314930
- FDA center
- Biologics
Other FDA inspections of Haematologic Technologies, LLC dba Prolytix
6| Date | Classification | Office | Project area |
|---|---|---|---|
| January 6, 2025 | Not classified | New England District Office | |
| July 30, 2021 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 27, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 28, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 11, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Haematologic Technologies, LLC dba Prolytix
- FDA Inspection 1258523 - 2025-01-06
- FDA Inspection 1147450 - 2021-07-30
- FDA Inspection 1098078 - 2019-06-27
- FDA Inspection 1027695 - 2017-07-28
- FDA Inspection 1013147 - 2017-05-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.